908 Devices — Third Quarter 2026 Earnings Summary

908 Devices reported third-quarter 2026 revenue of $19.0 million, representing a 35% year-over-year increase driven by growth in its FTIR portfolio and the addition of NIRLab revenue. The company achieved a record 308 device placements during the quarter, bringing the total installed base to 4,409 units, while recurring revenue accounted for 27% of total sales. Operating expenses decreased by $8.2 million to $15.5 million, primarily due to an $11.0 million non-cash reduction in the fair value of contingent consideration, resulting in a net loss of $4.6 million. The company raised its full-year 2026 revenue guidance to a range of $68.5 million to $70.0 million and ended the quarter with $99.1 million in cash and no outstanding debt.